 | • レポートコード：QYR9ST03570 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腺筋症治療の世界市場について調査・分析し、腺筋症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗炎症薬、ホルモン剤、子宮摘出術、その他）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腺筋症治療市場動向 ・主要企業別マーケットシェア ・腺筋症治療の種類別市場規模2014-2019 （抗炎症薬、ホルモン剤、子宮摘出術、その他） ・腺筋症治療の用途別市場規模2014-2019 （病院、診療所、外来手術センター） ・腺筋症治療の北米市場：主要企業・種類別/用途別市場規模 ・腺筋症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腺筋症治療の中国市場：主要企業・種類別/用途別市場規模 ・腺筋症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・腺筋症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・腺筋症治療のインド市場：主要企業・種類別/用途別市場規模 ・腺筋症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Johnson & Johnson、Novartis、Merck、Bayer、Ferring Holding、Speciality European Pharma） ・腺筋症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Adenomyosis disorder also known as Endometriosis interna, Adenomyosis uteri, Endometriosis uterine, or Adenomyometritis. Adenomyosis disorder occurs when endometrial tissue of the uterus endometrial cavity to grow into the uterus muscle that damage the uterine wall the uterine wall grow thicker. It may result into heavy bleeding and pain during the menstrual cysle. Considering the global scenario of the market, due to continuous innovation and rapid adoption of new drugs and therapies, North America is largest market for Adenomyosis Treatment. US is holding largest market share in North America region. European market is second largest, and especially the growth rate is higher in west European countries. On the other hand, due increasing knowledge of disease and treatments, developing healthcare infrastructure, and increasing healthcare expenditure, the Asia-Pacific (APAC) is fastest growing market for adenomyosis and expected to grow significantly during the forecast period.
In 2018, the global Adenomyosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Adenomyosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adenomyosis Treatment development in United States, Europe and China.
The key players covered in this study
Pfizer
Johnson & Johnson
Novartis
Merck
Bayer
Ferring Holding
Speciality European Pharma
…
Market segment by Type, the product can be split into
Anti-Inflammatory Drugs
Hormone Medications
Hysterectomy
Others
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Adenomyosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Adenomyosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Adenomyosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Adenomyosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Inflammatory Drugs
1.4.3 Hormone Medications
1.4.4 Hysterectomy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Adenomyosis Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Adenomyosis Treatment Market Size
2.2 Adenomyosis Treatment Growth Trends by Regions
2.2.1 Adenomyosis Treatment Market Size by Regions (2014-2025)
2.2.2 Adenomyosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Adenomyosis Treatment Market Size by Manufacturers
3.1.1 Global Adenomyosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Adenomyosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Adenomyosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Adenomyosis Treatment Key Players Head office and Area Served
3.3 Key Players Adenomyosis Treatment Product/Solution/Service
3.4 Date of Enter into Adenomyosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Adenomyosis Treatment Market Size by Type (2014-2019)
4.2 Global Adenomyosis Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Adenomyosis Treatment Market Size (2014-2019)
5.2 Adenomyosis Treatment Key Players in United States
5.3 United States Adenomyosis Treatment Market Size by Type
5.4 United States Adenomyosis Treatment Market Size by Application
6 Europe
6.1 Europe Adenomyosis Treatment Market Size (2014-2019)
6.2 Adenomyosis Treatment Key Players in Europe
6.3 Europe Adenomyosis Treatment Market Size by Type
6.4 Europe Adenomyosis Treatment Market Size by Application
7 China
7.1 China Adenomyosis Treatment Market Size (2014-2019)
7.2 Adenomyosis Treatment Key Players in China
7.3 China Adenomyosis Treatment Market Size by Type
7.4 China Adenomyosis Treatment Market Size by Application
8 Japan
8.1 Japan Adenomyosis Treatment Market Size (2014-2019)
8.2 Adenomyosis Treatment Key Players in Japan
8.3 Japan Adenomyosis Treatment Market Size by Type
8.4 Japan Adenomyosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Adenomyosis Treatment Market Size (2014-2019)
9.2 Adenomyosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Adenomyosis Treatment Market Size by Type
9.4 Southeast Asia Adenomyosis Treatment Market Size by Application
10 India
10.1 India Adenomyosis Treatment Market Size (2014-2019)
10.2 Adenomyosis Treatment Key Players in India
10.3 India Adenomyosis Treatment Market Size by Type
10.4 India Adenomyosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Adenomyosis Treatment Market Size (2014-2019)
11.2 Adenomyosis Treatment Key Players in Central & South America
11.3 Central & South America Adenomyosis Treatment Market Size by Type
11.4 Central & South America Adenomyosis Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Adenomyosis Treatment Introduction
12.1.4 Pfizer Revenue in Adenomyosis Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Adenomyosis Treatment Introduction
12.2.4 Johnson & Johnson Revenue in Adenomyosis Treatment Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Adenomyosis Treatment Introduction
12.3.4 Novartis Revenue in Adenomyosis Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Adenomyosis Treatment Introduction
12.4.4 Merck Revenue in Adenomyosis Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Adenomyosis Treatment Introduction
12.5.4 Bayer Revenue in Adenomyosis Treatment Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Ferring Holding
12.6.1 Ferring Holding Company Details
12.6.2 Company Description and Business Overview
12.6.3 Adenomyosis Treatment Introduction
12.6.4 Ferring Holding Revenue in Adenomyosis Treatment Business (2014-2019)
12.6.5 Ferring Holding Recent Development
12.7 Speciality European Pharma
12.7.1 Speciality European Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Adenomyosis Treatment Introduction
12.7.4 Speciality European Pharma Revenue in Adenomyosis Treatment Business (2014-2019)
12.7.5 Speciality European Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Adenomyosis Treatment Key Market Segments
Table Key Players Adenomyosis Treatment Covered
Table Global Adenomyosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Adenomyosis Treatment Market Size Market Share by Type 2014-2025
Figure Anti-Inflammatory Drugs Figures
Table Key Players of Anti-Inflammatory Drugs
Figure Hormone Medications Figures
Table Key Players of Hormone Medications
Figure Hysterectomy Figures
Table Key Players of Hysterectomy
Figure Others Figures
Table Key Players of Others
Table Global Adenomyosis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Adenomyosis Treatment Report Years Considered
Table Global Adenomyosis Treatment Market Size 2014-2025 (Million US$)
Figure Global Adenomyosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Adenomyosis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Adenomyosis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Adenomyosis Treatment Market Share by Regions 2014-2019
Figure Global Adenomyosis Treatment Market Share by Regions 2014-2019
Figure Global Adenomyosis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Adenomyosis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Adenomyosis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Adenomyosis Treatment Market Share by Manufacturers in 2018
Table Global Adenomyosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Adenomyosis Treatment Product/Solution/Service
Table Date of Enter into Adenomyosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Adenomyosis Treatment Market Size Share by Type (2014-2019)
Figure Global Adenomyosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Adenomyosis Treatment Market Size Share by Application (2014-2019)
Figure Global Adenomyosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Adenomyosis Treatment Revenue Market Share by Application in 2018
Figure United States Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Adenomyosis Treatment Market Share (2018-2019)
Table United States Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Adenomyosis Treatment Market Share by Type (2014-2019)
Table United States Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Adenomyosis Treatment Market Share by Application (2014-2019)
Figure Europe Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Adenomyosis Treatment Market Share (2018-2019)
Table Europe Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Adenomyosis Treatment Market Share by Type (2014-2019)
Table Europe Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Adenomyosis Treatment Market Share by Application (2014-2019)
Figure China Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Adenomyosis Treatment Market Share (2018-2019)
Table China Adenomyosis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Adenomyosis Treatment Market Share by Type (2014-2019)
Table China Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Adenomyosis Treatment Market Share by Application (2014-2019)
Figure Japan Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Adenomyosis Treatment Market Share (2018-2019)
Table Japan Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Adenomyosis Treatment Market Share by Type (2014-2019)
Table Japan Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Adenomyosis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Adenomyosis Treatment Market Share (2018-2019)
Table Southeast Asia Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Adenomyosis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Adenomyosis Treatment Market Share by Application (2014-2019)
Figure India Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Adenomyosis Treatment Market Share (2018-2019)
Table India Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Adenomyosis Treatment Market Share by Type (2014-2019)
Table India Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Adenomyosis Treatment Market Share by Application (2014-2019)
Figure Central & South America Adenomyosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Adenomyosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Adenomyosis Treatment Market Share (2018-2019)
Table Central & South America Adenomyosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Adenomyosis Treatment Market Share by Type (2014-2019)
Table Central & South America Adenomyosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Adenomyosis Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Adenomyosis Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Merck Recent Development
Table Bayer Company Details
Table Bayer Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Bayer Recent Development
Table Ferring Holding Company Details
Table Ferring Holding Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Ferring Holding Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Ferring Holding Recent Development
Table Speciality European Pharma Company Details
Table Speciality European Pharma Revenue in Adenomyosis Treatment Business (2014-2019)(Million US$)
Figure Speciality European Pharma Revenue Growth Rate in Adenomyosis Treatment Business (2014-2019)
Table Speciality European Pharma Recent Development
Table Global Adenomyosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Adenomyosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Adenomyosis Treatment Market Size Share by Regions in 2025
Figure United States Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Adenomyosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Adenomyosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Adenomyosis Treatment Market Size by Product (2019-2025)
Figure Global Adenomyosis Treatment Market Size by Product in 2025
Table Global Adenomyosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Adenomyosis Treatment Market Size by Application (2019-2025)
Figure Global Adenomyosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
成長ホルモン欠乏症治療の世界市場：市場規模・現状・予測 Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.The primary factor contributing to the growth of global growth hormone deficien…- 前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…
- 免疫介在性炎症性疾患治療の世界市場：市場規模・現状・予測 Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …